Oncologic radiotherapy-induced implantable cardioverter-defibrillator malfunctions: a real-time, in-vitro evaluation

Back

ESC Premium Access

Oncologic radiotherapy-induced implantable cardioverter-defibrillator malfunctions: a real-time, in-vitro evaluation

Session: Optimizing device therapy for arrhythmia

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor E. Di Girolamo (Lanciano, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Enrico Di Girolamo

Lanciano Renzetti Hospital, Lanciano (Italy)

0 follower

7 more presentations in this session

Experience with the wearable cardioverter-defibrillator by disease etiology: results from the wearit-II registry

Speaker: Associate Professor V. Kutyifa (Rochester, US)

The use of wearable cardioverter defibrillator in France

Speaker: Professor E. Marijon (Paris, FR)

Access

Abstract

When do cardiac rhythm management device complications occur?

Speaker: Doctor C. Brough (Cheshire, GB)

Role of implantation access on complication rates in pacemaker implantation

Speaker: Doctor K. Bestehorn (Dresden, DE)

Influence of transvenous lead extraction procedure on function of tricuspid apparatus

Speaker: Professor A. Polewczyk (Kielce, PL)

Access the full session

Optimizing device therapy for arrhythmia

Speakers: Doctor E. Di Girolamo, Associate Professor V. Kutyifa, Professor E. Marijon, Doctor C. Brough, Doctor K. Bestehorn...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources